Whole Body Vibration in Middle Aged Men
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Dynatronics VF5 Model vibration platform, Placebo Dynatronics VF5 Model vibration platform.
- Who it may be relevant to
- Registry conditions: Bone Density, Muscle Weakness. Basic parameters: from 50 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Saudi Arabia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of Whole-Body Vibration on Bone Mineral Density, Hand Grip Strength, and Vitamin D Levels in Middle-Aged Men: a Preliminary Clinical Trial
Overview
This study aims of this clinical trial is to evaluate the effect of an 8-week Whole Body Vibration (WBV) intervention on Bone Mineral Density (BMD), hand grip strength, and vitamin D levels in middle-aged men. Findings from this study will contribute to understanding whether WBV is a viable alternative to conventional exercise, especially for those with limitations in physical activity. Study Objectives: • Primary Objective: To assess the effectiveness of an 8-week WBV intervention in improving BMD, hand grip strength, and vitamin D levels compared to a placebo intervention.
Interventions
- Device Dynatronics VF5 Model vibration platform
The Dynatronics VF5 Model vibration platform is a specialized therapeutic device designed for rehabilitation and wellness applications. Utilizing advanced vibration technology, it provides whole-body vibration therapy that can enhance muscle strength, improve flexibility, and promote overall physical well-being. The platform features adjustable frequency and amplitude settings, allowing customization based on individual needs. Its user-friendly interface and robust, durable design make it suitab - Device Placebo Dynatronics VF5 Model vibration platform
Placebo intensity with vertical vibration of 0.2 mm
Primary outcome measures
- Bone Density [Time frame: 8 weeks]
- Grip Strength [Time frame: 8 weeks]
- Vitamin D [Time frame: 8 weeks]
Eligibility criteria
Inclusion criteria
- Male participants aged 50 years or older
- Participants with physical activity or exercise program involvement
- Participants with no history of serious medical conditions such as tumors, fractures, epilepsy, cardiac disease, or stroke within the past year.
- Participants must be non-smokers and not receiving hormone or calcium supplement therapy
Exclusion criteria
- Participants unable to stand on the WBV platform
- Participants with conditions contraindicating vibration therapy
- Participants participating in other clinical trials
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Saudi Arabia · 1 center
- prince Mutaib bin Abdulaziz hospital — Sakakah
Identifiers
NCT: NCT06644469 · JoufU